Recent Publications

Estimated kidney function in children and young adults with spina bifida: A retrospective cohort study.
Chu DI, Balmert LC, Arkin CM, Meyer T, Rosoklija I, Li B, Hodgkins KS, Furth SL, Cheng EY, Yerkes EB, Isakova T.
Neurourol Urodyn. 2019 Jul 8. doi: 10.1002/nau.24092. [Epub ahead of print]
Nivolumab in metastatic adrenocortical carcinoma: results of a phase II trial.
Carneiro BA,… Abdulkadir SA …
J Clin Endocrinol Metab. 2019 Jul 5. pii: jc.2019-00600. doi: 10.1210/jc.2019-00600. [Epub ahead of print]
Palladium-catalyzed coupling reactions on functionalized 2-trifluoromethyl-4-chromenone scaffolds. Synthesis of highly functionalized trifluoromethyl-heterocycles.
Izquierdo J, Jain AD, Abdulkadir SA, Schiltz GE.
Synthesis (Stuttg). 2019 Mar;51(6):1342-1352. doi: 10.1055/s-0037-1610669.
DNA-dependent protein kinase drives prostate cancer progression through transcriptional regulation of the Wnt signaling pathway.
Kothari V, Goodwin JF, Zhao SG, Drake JM, Yin Y, Chang SL, Evans JR, Wilder-Romans K, Gabbara K, Dylgjeri E, Chou J, …
Clin Cancer Res. 2019 Jul 2. pii: clincanres.2387.2018. doi: 10.1158/1078-0432.CCR-18-2387. [Epub ahead of print]
Computer-enhanced visual learning: open primary, nerve-sparing retroperitoneal lymph node dissection.
Douglass L, Kovac E, Campbell S, Stephenson A, Meade P, Maizels M.
J Pediatr Urol. 2019 May;15(3):270-272. doi: 10.1016/j.jpurol.2019.06.002. No abstract available.
Tumor Location May Predict Adverse Pathology and Survival Following Definitive Treatment for Bladder Cancer: A National Cohort Study.
Weiner AB, Desai AS, Meeks JJ.
Eur Urol Oncol. 2019 May;2(3):304-310. doi: 10.1016/j.euo.2018.08.018. Epub 2018 Sep 14.
Protease-activated receptor 2 activates CRAC-mediated Ca2+ influx to cause prostate smooth muscle contraction.
Paul M, Murphy SF, Hall C, Schaeffer AJ, Thumbikat P.
FASEB Bioadv. 2019 Apr;1(4):255-264. doi: 10.1096/fba.2018-00024. Epub 2019 Jan 3.
Fertility Preservation for a Teenager with Differences (Disorders) of Sex Development: An Ethics Case Study.
Campo-Engelstein L, Chen D, Baratz AB, Johnson EK, Finlayson C.
J Clin Ethics. 2019 Summer;30(2):143-153.
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical Implications.
Alshalalfa M,… Schaeffer EM …
Eur Urol Oncol. 2019 Jul;2(4):405-412. doi: 10.1016/j.euo.2019.05.001. Epub 2019 Jun 2.
Limited Upstaging in Luminal Subtype Tumors: Ready for Clinical Practice?
Meeks JJ, McConkey DJ.
Eur Urol. 2019 May 30. pii: S0302-2838(19)30432-4. doi: 10.1016/j.eururo.2019.05.025. [Epub ahead of print] No abstract available.
Reply to Zeynep G. Gul, Alberto Martini, and Carl A. Olsson's Letter to the Editor re: Jacob A. Burns, Adam B. Weiner, William J. Catalona, et al. Inflammatory Bowel Disease and the Risk of Prostate Cancer. Eur Urol 2019;75:846-52.
Burns JA, Weiner AB, Kundu S.
Eur Urol. 2019 May 28. pii: S0302-2838(19)30434-8. doi: 10.1016/j.eururo.2019.05.027. [Epub ahead of print] No abstract available.
An update on synthetic high-density lipoprotein-like nanoparticles for cancer therapy.
Henrich SE, Thaxton CS.
Expert Rev Anticancer Ther. 2019 Jun;19(6):515-528. doi: 10.1080/14737140.2019.1624529. Epub 2019 May 31.
Can post-neoadjuvant therapy molecular classification guide future treatment selection for muscle-invasive bladder cancer?
VanderWeele DJ, Meeks JJ, Hussain M.
Transl Androl Urol. 2019 Mar;8(Suppl 1):S91-S92. doi: 10.21037/tau.2018.12.07. No abstract available.
Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma.
Alshalalfa M, Liu Y, Wyatt AW, Gibb EA, Tsai HK, Erho N, Lehrer J, Takhar M, Ramnarine VR, Collins CC, Den RB, …
Int J Cancer. 2019 May 24. doi: 10.1002/ijc.32430. [Epub ahead of print]
Association of Black Race With Prostate Cancer-Specific and Other-Cause Mortality.
Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, Amling CL, Aronson WJ, Kane CJ, Terris MK, …
JAMA Oncol. 2019 May 23. doi: 10.1001/jamaoncol.2019.0826. [Epub ahead of print]
Editorial Comment.
Johnson EK, Rosoklija I.
J Urol. 2019 Aug;202(2):405. doi: 10.1097/01.JU.0000559958.13903.c1. Epub 2019 Jul 8. No abstract available.
African American Specific Gene Panel Predictive of Poor Prostate Cancer Outcome.
Echevarria MI, Awasthi S, Cheng CH, Berglund AE, Rounbehler RJ, Gerke TA, Takhar M, Davicioni E, Klein EA, Freedland SJ, …
J Urol. 2019 Aug;202(2):247-255. doi: 10.1097/JU.0000000000000193. Epub 2019 Jul 8.
Computer-enhanced visual learning interactive: judging suitability for newborn circumcision.
Maizels M, Meade P.
J Pediatr Urol. 2019 Apr;15(2):189-191. doi: 10.1016/j.jpurol.2019.02.025. No abstract available.
Prostate cancer in sexual minorities and the influence of HIV status.
Amarasekera C, Wong V, Yura E, Manjunath A, Schaeffer E, Kundu S.
Nat Rev Urol. 2019 Jul;16(7):404-421. doi: 10.1038/s41585-019-0194-2. Review.
Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.
Psutka SP, Barocas DA, Catto JWF, Gore JL, Lee CT, Morgan TM, Master VA, Necchi A, Rouprêt M, Boorjian SA.
Eur Urol Oncol. 2018 Sep;1(4):292-304. doi: 10.1016/j.euo.2018.05.010. Epub 2018 Jun 19. Review.